232 related articles for article (PubMed ID: 10470236)
1. Development of a new automated enzyme immunoassay for the determination of neuron-specific enolase.
Sterk M; Oenings A; Eymann E; Roos W
Anticancer Res; 1999; 19(4A):2759-62. PubMed ID: 10470236
[TBL] [Abstract][Full Text] [Related]
2. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
Schmitt UM; Stieber P; Hasholzner U; Pahl H; Hofmann K; Fateh-Moghadam A
Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):679-82. PubMed ID: 8877347
[TBL] [Abstract][Full Text] [Related]
3. Practicable enzyme immunoassay for neuron-specific enolase in human serum.
Kimura S; Uchikawa H; Yamamoto R; Kato K
J Appl Biochem; 1984; 6(5-6):319-24. PubMed ID: 6399287
[TBL] [Abstract][Full Text] [Related]
4. LIAISON hCG--an automated chemiluminescent immunoassay for the determination of human chorionic gonadotropin (hCG).
Oed M; Amtmann R; Löwer Y; Schlett R; Mack M
Anticancer Res; 1999; 19(4A):2735-7. PubMed ID: 10470231
[TBL] [Abstract][Full Text] [Related]
5. Automated Cobas Core PSA assays: sensitive, precise, and specific measurement of PSA-total and PSA-total/PSA-free ratio.
Groche D; Trebo R; Peters I; Pfleiderer P
Anticancer Res; 1999; 19(4A):2767-70. PubMed ID: 10470238
[TBL] [Abstract][Full Text] [Related]
6. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
Muley T; Ebert W; Stieber P; Raith H; Holdenrieder S; Nagel D; Fürst H; Roth HJ; Luthe H; Blijenberg BG; Gurr E; Uhl W; von Pawel J; Drings P
Clin Chem Lab Med; 2003 Jan; 41(1):95-103. PubMed ID: 12636057
[TBL] [Abstract][Full Text] [Related]
7. [Neuron-specific enolase as a new tumor marker].
Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1744-53. PubMed ID: 6349546
[TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of IMMULITE TPS: a comparison with TPS IRMA.
Einarsson R; Lei JD; Ullrich A; Van Dalen A
Anticancer Res; 1999; 19(4A):2743-7. PubMed ID: 10470233
[TBL] [Abstract][Full Text] [Related]
9. LIAISON Ferritin--an automated chemiluminescent immunoassay for the determination of Ferritin.
König B; Oed M; Kunz A; Schlett R; Mack M
Anticancer Res; 1999; 19(4A):2739-41. PubMed ID: 10470232
[TBL] [Abstract][Full Text] [Related]
10. Chemiluminescence enzyme immunoassay using magnetic nanoparticles for detection of neuron specific enolase in human serum.
Fu X; Meng M; Zhang Y; Yin Y; Zhang X; Xi R
Anal Chim Acta; 2012 Apr; 722():114-8. PubMed ID: 22444542
[TBL] [Abstract][Full Text] [Related]
11. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)--multi-centre study results. The PSA Study Group.
Schambeck CM
Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):541-7. PubMed ID: 8547440
[TBL] [Abstract][Full Text] [Related]
13. [Importance of hemolysis on neuron-specific enolase measurement].
Planche V; Brochet C; Bakkouch A; Bernard M
Ann Biol Clin (Paris); 2010; 68(2):239-42. PubMed ID: 20348052
[TBL] [Abstract][Full Text] [Related]
14. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
Schneider J; Philipp M; Salewski L; Velcovsky HG
Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
[TBL] [Abstract][Full Text] [Related]
15. Multiplexing determination of small cell lung cancer biomarkers and their isovariants in serum by immunocapture LC-MS/MS.
Torsetnes SB; Levernæs MS; Broughton MN; Paus E; Halvorsen TG; Reubsaet L
Anal Chem; 2014 Jul; 86(14):6983-92. PubMed ID: 24945626
[TBL] [Abstract][Full Text] [Related]
16. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
[TBL] [Abstract][Full Text] [Related]
17. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer].
Wei T; Luo RC; Zuo Q; Zhang JY; Miao JX; Lu HF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621
[TBL] [Abstract][Full Text] [Related]
18. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
[TBL] [Abstract][Full Text] [Related]
19. Cobas Core CA 19-9 II EIA: new CA 19-9 enzyme immunoassay with high correlation to radioimmunoassays.
Birk B; Henne V; Hipp B; Meyer A
Anticancer Res; 1997; 17(4B):2911-4. PubMed ID: 9329561
[TBL] [Abstract][Full Text] [Related]
20. Value of tumour and inflammatory markers in lung cancer.
Oremek GM; Sauer-Eppel H; Bruzdziak TH
Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
